Qiagen NV (QGEN)
42.63
-0.60
(-1.39%)
USD |
NYSE |
Nov 13, 16:00
42.64
0.00 (0.00%)
After-Hours: 20:00
Qiagen Max Drawdown (5Y): 37.44% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 37.44% |
| September 30, 2024 | 37.44% |
| August 31, 2024 | 37.44% |
| July 31, 2024 | 38.61% |
| June 30, 2024 | 38.61% |
| May 31, 2024 | 38.61% |
| April 30, 2024 | 38.61% |
| March 31, 2024 | 38.61% |
| February 29, 2024 | 38.61% |
| January 31, 2024 | 38.61% |
| December 31, 2023 | 38.61% |
| November 30, 2023 | 38.61% |
| October 31, 2023 | 38.61% |
| September 30, 2023 | 38.61% |
| August 31, 2023 | 38.61% |
| July 31, 2023 | 38.61% |
| June 30, 2023 | 38.61% |
| May 31, 2023 | 38.61% |
| April 30, 2023 | 38.61% |
| March 31, 2023 | 38.61% |
| February 28, 2023 | 38.61% |
| January 31, 2023 | 38.61% |
| December 31, 2022 | 38.61% |
| November 30, 2022 | 38.61% |
| October 31, 2022 | 38.61% |
| Date | Value |
|---|---|
| September 30, 2022 | 38.61% |
| August 31, 2022 | 38.61% |
| July 31, 2022 | 38.61% |
| June 30, 2022 | 38.61% |
| May 31, 2022 | 38.61% |
| April 30, 2022 | 38.61% |
| March 31, 2022 | 38.61% |
| February 28, 2022 | 38.61% |
| January 31, 2022 | 38.61% |
| December 31, 2021 | 38.61% |
| November 30, 2021 | 38.61% |
| October 31, 2021 | 38.61% |
| September 30, 2021 | 38.61% |
| August 31, 2021 | 38.61% |
| July 31, 2021 | 38.61% |
| June 30, 2021 | 38.61% |
| May 31, 2021 | 38.61% |
| April 30, 2021 | 38.61% |
| March 31, 2021 | 38.61% |
| February 28, 2021 | 38.61% |
| January 31, 2021 | 38.61% |
| December 31, 2020 | 38.61% |
| November 30, 2020 | 38.61% |
| October 31, 2020 | 38.61% |
| September 30, 2020 | 38.61% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
37.44%
Minimum
Aug 2024
38.61%
Maximum
Nov 2019
38.55%
Average
38.61%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| LENZ Therapeutics Inc | -- |
| Oruka Therapeutics Inc | -- |
| Boston Scientific Corp | 43.49% |
| uniQure NV | 94.93% |
| ProQR Therapeutics NV | 97.50% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -0.5195 |
| Beta (5Y) | 0.4084 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 23.29% |
| Historical Sharpe Ratio (5Y) | 0.204 |
| Historical Sortino (5Y) | 0.3421 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 10.90% |